Newsroom

CHICAGO--(BUSINESS WIRE)--Neal Gerber Eisenberg (NGE) is pleased to announce that Brian P. Murray has joined the firm as a partner in its Intellectual Property practice group, with a focus on life sciences. Brian brings more than a decade of experience advising clients on complex intellectual property matters across the pharmaceutical, biotechnology, and advanced technology sectors. His practice spans both patent litigation and strategic counseling, with significant experience serving as lead c...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 5/26/2026 Issue ¦ Bank of Montreal - Series CBL35 GBP 750,000,000 FRN due September 2027     ISIN Number ¦ XS2631051682 ISIN Reference ¦ 263105168 Issue Nomin GBP ¦ 750000000 Period ¦ 3/2/2026 to 6/2/2026   Payment Date 6/2/2026 Number of Days ¦ 92 Rate ¦ 4.39653   Denomination GBP ¦ 1000   ¦ 750000000   ¦       Amount Payable per Denomination ¦ 11.08   ¦ 8311248.49   ¦       Bank of New York     Ra...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 25.05.2026 SDVI.LN IE000YVOQ2A3 40,361.00 USD 1,137,375.53 28.180  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Momentum UCITS ETF 25.05.2026 FTMO.LN IE000CY30YV9 3,050,002.00 USD 91,250,737.54 29.918  ...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, éligible PEA/PME, « Median » ou « La Société »), fabricant d’eyonis®, une suite de logiciels dispositifs médicaux basés sur l’intelligence artificielle (IA) pour le diagnostic précoce des cancers, et un leader mondial de la fourniture d’analyses d’images par IA et de services d’imagerie centralisés pour les essais cliniques en oncologie de l’industrie biopharmaceutique, annonce aujourd’hui que...

ANTWERPEN, België--(BUSINESS WIRE)--GEREGULEERDE INFORMATIE In overeenstemming met artikel 14 van de Belgische Transparantiewet van 2 mei 2007 maakt Azelis Group NV (Brussels:AZE) bekend dat het 2 transparantiekennisgevingen heeft ontvangen van UBS Group AG op 21 mei 2026 en 26 mei 2026. 1. Samenvatting van de kennisgevingen UBS Group AG heeft in een kennisgeving gedateerd op 21 mei 2026 gemeld dat op 19 mei 2026, na een verwerving van gelijkgestelde financiële instrumenten, UBS Group AG (reken...

ANTWERP, Belgium--(BUSINESS WIRE)--REGULATED INFORMATION In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV (Brussels:AZE) announces that on 21 May 2026 and 26 May 2026, it has received 2 transparency notifications from UBS Group AG. 1. Summary of the notifications UBS Group AG reported in its notification dated 21 May 2026, that on 19 May 2026, following an acquisition of equivalent financial instruments, UBS Group AG (taking into account the holding o...

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 18/05/2026 FR0014000MR3 20 000 59.6316 CEUX EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 18/05/2026 FR0014000MR3 40 000 59.5530 XPAR EUROFINS SCIENTIFC 529900JEHFM47DYY3S57 19/05/2...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies (FR0011049824, ALMDT, “Median” or the “Company”), manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as Medical Devices (SaMD) for early cancer diagnosis, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, announced today that the Company will be participating in the 2026 American Society of Clinical Oncology (ASCO) Ann...

LONDON--(BUSINESS WIRE)--  As Agent Bank, please be advised of the following rate determined on: 5/22/2026 Issue ¦ Toyota Motor Finance (Netherlands) B.V. Series No 410 SEK 500,000,000 FRN due May 2029     ISIN Number ¦ XS3079585033 ISIN Reference ¦ 307958503 Issue Nomin SEK ¦ 500000000 Period ¦ 5/26/2026 to 8/24/2026   Payment Date 8/24/2026 Number of Days ¦ 90 Rate ¦ 2.732   Denomination SEK ¦ 2000000   ¦ 500000000   ¦       Amount Payable per Denomination ¦ 13660   ¦ 3415000   ¦       Bank o...